TriSalus Life Sciences (TLSI) Debt Ratio (2022 - 2026)

TriSalus Life Sciences has reported Debt Ratio for 5 years, with the latest figure at 0.47 in Q1 2026.

• For the quarter ending Q1 2026, Debt Ratio fell 57.92% year-over-year to 0.47; the trailing twelve-month figure through Mar 2026 stood at 0.47 (down 57.92% YoY), and the FY2025 full-year result was 0.94, up 1.52% from the prior year.
• Debt Ratio for Q1 2026 stood at 0.47, down from 0.94 in the prior quarter.
• The five-year high for Debt Ratio was 1.11 in Q1 2025, with the low at 0.11 in Q4 2022.
• Historically, Debt Ratio has averaged 0.7 across 5 years, with a median of 0.79 in 2024.
• Annual changes were most pronounced in 2025 — Debt Ratio gained 19.01% — and 2026, when it slumped 57.92%.
• TriSalus Life Sciences' Debt Ratio stood at 0.11 in 2022, then surged by 636.44% to 0.82 in 2023, then rose by 12.22% to 0.92 in 2024, then advanced by 1.52% to 0.94 in 2025, then sank by 50.17% to 0.47 in 2026.
• The last three Debt Ratio figures came in at 0.47 (Q1 2026), 0.94 (Q4 2025), and 0.9 (Q3 2025), per Business Quant data.